Recent Material Events - Viropharma, Inc (VPHM)

Filing Date	Description
2008-09-12	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-09-03	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-07-30	On July 30, 2008, ViroPharma Incorporated issued a press release announcing its financial results for its second quarter and six months ended June 30, 2008. A copy of the press release is set forth as Exhibit 99.1 attached hereto. ...
2008-07-18	ViroPharma Incorporated (the “ Company ”) entered into an Agreement and Plan of Merger, dated July 15, 2008 (the “ Merger Agreement ”), with Lev Pharmaceuticals, Inc., a Delaware corporation (“ Lev ”), and HAE Acquisitio ...
2008-07-15	Additionally, the Company agreed to make a $20 million investment in Lev, at signing, by purchasing 9,661,836 shares of Lev common stock at a 10 percent premium to the five day average closing price of Lev’s shares for the period ending Friday, ...
2008-05-29	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-05-28	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-05-20	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-04-30	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-04-17	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...